Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$6.63 - $10.69 $238 - $384
36 Added 0.18%
20,248 $163,000
Q4 2023

Feb 13, 2024

SELL
$3.61 - $7.76 $296 - $636
-82 Reduced 0.4%
20,212 $138,000
Q3 2023

Nov 13, 2023

BUY
$4.68 - $9.26 $3,374 - $6,676
721 Added 3.68%
20,294 $101,000
Q2 2023

Aug 04, 2023

BUY
$8.5 - $10.38 $34 - $41
4 Added 0.02%
19,573 $178,000
Q1 2023

May 12, 2023

BUY
$7.53 - $10.95 $2,936 - $4,270
390 Added 2.03%
19,569 $184,000
Q4 2022

Feb 10, 2023

SELL
$9.44 - $13.09 $660 - $916
-70 Reduced 0.36%
19,179 $191,000
Q3 2022

Nov 14, 2022

BUY
$8.14 - $12.25 $2,214 - $3,332
272 Added 1.43%
19,249 $229,000
Q2 2022

Aug 12, 2022

SELL
$6.99 - $10.0 $1,530 - $2,190
-219 Reduced 1.14%
18,977 $155,000
Q1 2022

May 13, 2022

SELL
$7.26 - $10.7 $9,808 - $14,455
-1,351 Reduced 6.58%
19,196 $152,000
Q4 2021

Feb 11, 2022

SELL
$8.8 - $16.0 $2,904 - $5,280
-330 Reduced 1.58%
20,547 $193,000
Q3 2021

Nov 12, 2021

SELL
$15.23 - $21.72 $7,554 - $10,773
-496 Reduced 2.32%
20,877 $330,000
Q2 2021

Aug 13, 2021

SELL
$17.8 - $23.5 $5,251 - $6,932
-295 Reduced 1.36%
21,373 $462,000
Q1 2021

May 07, 2021

BUY
$17.18 - $22.6 $8,830 - $11,616
514 Added 2.43%
21,668 $439,000
Q4 2020

Feb 12, 2021

SELL
$11.5 - $17.96 $6,980 - $10,901
-607 Reduced 2.79%
21,154 $379,000
Q3 2020

Nov 04, 2020

SELL
$10.62 - $13.12 $5,267 - $6,507
-496 Reduced 2.23%
21,761 $253,000
Q2 2020

Aug 12, 2020

BUY
$7.35 - $10.81 $16,000 - $23,533
2,177 Added 10.84%
22,257 $206,000
Q1 2020

May 04, 2020

SELL
$8.38 - $17.34 $9,712 - $20,097
-1,159 Reduced 5.46%
20,080 $209,000
Q4 2019

Feb 05, 2020

SELL
$11.18 - $18.6 $2,012 - $3,348
-180 Reduced 0.84%
21,239 $380,000
Q3 2019

Nov 08, 2019

SELL
$12.09 - $20.46 $1,789 - $3,028
-148 Reduced 0.69%
21,419 $267,000
Q2 2019

Aug 13, 2019

SELL
$18.5 - $25.47 $1,054 - $1,451
-57 Reduced 0.26%
21,567 $427,000
Q1 2019

May 06, 2019

SELL
$14.62 - $22.13 $10,248 - $15,513
-701 Reduced 3.14%
21,624 $455,000
Q4 2018

Feb 13, 2019

SELL
$17.09 - $38.25 $2,922 - $6,540
-171 Reduced 0.76%
22,325 $456,000
Q3 2018

Nov 09, 2018

BUY
$34.05 - $55.9 $26,593 - $43,657
781 Added 3.6%
22,496 $829,000
Q2 2018

Aug 08, 2018

BUY
$36.15 - $52.5 $134,767 - $195,720
3,728 Added 20.73%
21,715 $1.09 Million
Q1 2018

May 07, 2018

SELL
$24.4 - $40.25 $10,077 - $16,623
-413 Reduced 2.24%
17,987 $657,000
Q4 2017

Feb 09, 2018

BUY
$18.5 - $28.6 $1,628 - $2,516
88 Added 0.48%
18,400 $521,000
Q3 2017

Nov 09, 2017

BUY
$14.65 - $19.35 $268,270 - $354,337
18,312
18,312 $354,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $661M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.